Table of Content

1 Radiopharmaceuticals in Nuclear Medical Market Overview
1.1 Radiopharmaceuticals in Nuclear Medical Product Scope
1.2 Radiopharmaceuticals in Nuclear Medical Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Type (2016 & 2021 & 2027)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Radiopharmaceuticals in Nuclear Medical Segment by Application
1.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Industrial
1.4 Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts (2016-2027)
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Radiopharmaceuticals in Nuclear Medical Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Radiopharmaceuticals in Nuclear Medical Price Trends (2016-2027)

2 Radiopharmaceuticals in Nuclear Medical Estimates and Forecasts by Region
2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Radiopharmaceuticals in Nuclear Medical Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2016-2021)
2.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2016-2021)
2.3 Global Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
2.4.2 Europe Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
2.4.3 China Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
2.4.4 Japan Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
2.4.6 India Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)

3 Global Radiopharmaceuticals in Nuclear Medical Competition Landscape by Players
3.1 Global Top Radiopharmaceuticals in Nuclear Medical Players by Sales (2016-2021)
3.2 Global Top Radiopharmaceuticals in Nuclear Medical Players by Revenue (2016-2021)
3.3 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2020)
3.4 Global Radiopharmaceuticals in Nuclear Medical Average Price by Company (2016-2021)
3.5 Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Radiopharmaceuticals in Nuclear Medical Market Size by Type
4.1 Global Radiopharmaceuticals in Nuclear Medical Historic Market Review by Type (2016-2021)
4.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
4.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2016-2021)
4.1.3 Global Radiopharmaceuticals in Nuclear Medical Price by Type (2016-2021)
4.2 Global Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Type (2022-2027)
4.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2022-2027)
4.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Type (2022-2027)

5 Global Radiopharmaceuticals in Nuclear Medical Market Size by Application
5.1 Global Radiopharmaceuticals in Nuclear Medical Historic Market Review by Application (2016-2021)
5.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
5.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application (2016-2021)
5.1.3 Global Radiopharmaceuticals in Nuclear Medical Price by Application (2016-2021)
5.2 Global Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2022-2027)
5.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Application (2022-2027)
5.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Application (2022-2027)

6 North America Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
6.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Company
6.1.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
6.1.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
6.2 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
6.2.1 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
6.2.2 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
6.3 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
6.3.1 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application (2016-2021)
6.3.2 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application (2022-2027)

7 Europe Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
7.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Company
7.1.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
7.1.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
7.2 Europe Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
7.2.1 Europe Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
7.2.2 Europe Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
7.3 Europe Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)

8 China Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
8.1 China Radiopharmaceuticals in Nuclear Medical Sales by Company
8.1.1 China Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
8.1.2 China Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
8.2 China Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
8.2.1 China Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
8.2.2 China Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
8.3 China Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
8.3.1 China 166 Sales Breakdown by Application (2016-2021)
8.3.2 China 166 Sales Breakdown by Application (2022-2027)

9 Japan Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
9.1 Japan Radiopharmaceuticals in Nuclear Medical Sales by Company
9.1.1 Japan Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
9.1.2 Japan Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
9.2 Japan Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
9.2.1 Japan Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
9.2.2 Japan Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
9.3 Japan Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
10.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales by Company
10.1.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
10.1.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
10.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
10.2.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
11.1 India Radiopharmaceuticals in Nuclear Medical Sales by Company
11.1.1 India Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
11.1.2 India Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
11.2 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
11.2.1 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
11.2.2 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
11.3 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
11.3.1 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application (2016-2021)
11.3.2 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Radiopharmaceuticals in Nuclear Medical Business
12.1 Bracco Imaging
12.1.1 Bracco Imaging Corporation Information
12.1.2 Bracco Imaging Business Overview
12.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
12.1.5 Bracco Imaging Recent Development
12.2 Cambridge Isotope Laboratories
12.2.1 Cambridge Isotope Laboratories Corporation Information
12.2.2 Cambridge Isotope Laboratories Business Overview
12.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Products Offered
12.2.5 Cambridge Isotope Laboratories Recent Development
12.3 Cardinal Health
12.3.1 Cardinal Health Corporation Information
12.3.2 Cardinal Health Business Overview
12.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Products Offered
12.3.5 Cardinal Health Recent Development
12.4 Medtronic
12.4.1 Medtronic Corporation Information
12.4.2 Medtronic Business Overview
12.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Products Offered
12.4.5 Medtronic Recent Development
12.5 Eczacibasi-Monrol
12.5.1 Eczacibasi-Monrol Corporation Information
12.5.2 Eczacibasi-Monrol Business Overview
12.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Products Offered
12.5.5 Eczacibasi-Monrol Recent Development
12.6 Fujifilm Holdings Corporation
12.6.1 Fujifilm Holdings Corporation Corporation Information
12.6.2 Fujifilm Holdings Corporation Business Overview
12.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
12.6.5 Fujifilm Holdings Corporation Recent Development
12.7 GE Healthcare (Subsidiary Of General Electric Company)
12.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
12.7.2 GE Healthcare (Subsidiary Of General Electric Company) Business Overview
12.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Products Offered
12.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
12.8 IBA Group
12.8.1 IBA Group Corporation Information
12.8.2 IBA Group Business Overview
12.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Products Offered
12.8.5 IBA Group Recent Development
12.9 Lantheus Medical Imaging
12.9.1 Lantheus Medical Imaging Corporation Information
12.9.2 Lantheus Medical Imaging Business Overview
12.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
12.9.5 Lantheus Medical Imaging Recent Development
12.10 Nordion
12.10.1 Nordion Corporation Information
12.10.2 Nordion Business Overview
12.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Products Offered
12.10.5 Nordion Recent Development
12.11 Ntp Radioisotopes
12.11.1 Ntp Radioisotopes Corporation Information
12.11.2 Ntp Radioisotopes Business Overview
12.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Products Offered
12.11.5 Ntp Radioisotopes Recent Development
12.12 Siemens Healthcare
12.12.1 Siemens Healthcare Corporation Information
12.12.2 Siemens Healthcare Business Overview
12.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Products Offered
12.12.5 Siemens Healthcare Recent Development
12.13 Taiyo Nippon Sanso Corporation
12.13.1 Taiyo Nippon Sanso Corporation Corporation Information
12.13.2 Taiyo Nippon Sanso Corporation Business Overview
12.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
12.13.5 Taiyo Nippon Sanso Corporation Recent Development
12.14 Urenco Limited
12.14.1 Urenco Limited Corporation Information
12.14.2 Urenco Limited Business Overview
12.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Urenco Limited Radiopharmaceuticals in Nuclear Medical Products Offered
12.14.5 Urenco Limited Recent Development
12.15 Rotem Industries
12.15.1 Rotem Industries Corporation Information
12.15.2 Rotem Industries Business Overview
12.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Rotem Industries Radiopharmaceuticals in Nuclear Medical Products Offered
12.15.5 Rotem Industries Recent Development

13 Radiopharmaceuticals in Nuclear Medical Manufacturing Cost Analysis
13.1 Radiopharmaceuticals in Nuclear Medical Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
13.4 Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Radiopharmaceuticals in Nuclear Medical Distributors List
14.3 Radiopharmaceuticals in Nuclear Medical Customers

15 Market Dynamics
15.1 Radiopharmaceuticals in Nuclear Medical Market Trends
15.2 Radiopharmaceuticals in Nuclear Medical Drivers
15.3 Radiopharmaceuticals in Nuclear Medical Market Challenges
15.4 Radiopharmaceuticals in Nuclear Medical Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Radiopharmaceuticals in Nuclear Medical Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Radiopharmaceuticals in Nuclear Medical Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Radiopharmaceuticals in Nuclear Medical Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Region (2016-2021)
Table 5. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2016-2021)
Table 6. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Region (2016-2021)
Table 8. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Radiopharmaceuticals in Nuclear Medical Revenue Share Forecast by Region (2022-2027)
Table 12. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Company (2016-2021)
Table 14. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Company (2016-2021)
Table 16. Global Radiopharmaceuticals in Nuclear Medical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2020)
Table 17. Global Radiopharmaceuticals in Nuclear Medical Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Sites and Area Served
Table 19. Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Type (2016-2021)
Table 22. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Type (2016-2021)
Table 23. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Radiopharmaceuticals in Nuclear Medical Price (USD/MT) by Type (2016-2021)
Table 25. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Type (2022-2027)
Table 26. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Type (2022-2027)
Table 28. Global Radiopharmaceuticals in Nuclear Medical Price (USD/MT) by Type (2022-2027)
Table 29. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2016-2021)
Table 30. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Application (2016-2021)
Table 31. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Radiopharmaceuticals in Nuclear Medical Price (USD/MT) by Application (2016-2021)
Table 33. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Application (2022-2027)
Table 34. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Application (2022-2027)
Table 35. Global Radiopharmaceuticals in Nuclear Medical Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Application (2022-2027)
Table 37. Global Radiopharmaceuticals in Nuclear Medical Price (USD/MT) by Application (2022-2027)
Table 38. North America Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2016-2021)
Table 39. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2016-2021)
Table 40. North America Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2016-2021)
Table 42. North America Radiopharmaceuticals in Nuclear Medical Sales by Type (2016-2021) & (K MT)
Table 43. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
Table 44. North America Radiopharmaceuticals in Nuclear Medical Sales by Type (2022-2027) & (K MT)
Table 45. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2022-2027)
Table 46. North America Radiopharmaceuticals in Nuclear Medical Sales by Application (2016-2021) & (K MT)
Table 47. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
Table 48. North America Radiopharmaceuticals in Nuclear Medical Sales by Application (2022-2027) & (K MT)
Table 49. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2022-2027)
Table 50. Europe Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2016-2021)
Table 51. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2016-2021)
Table 52. Europe Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2016-2021)
Table 54. Europe Radiopharmaceuticals in Nuclear Medical Sales by Type (2016-2021) & (K MT)
Table 55. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
Table 56. Europe Radiopharmaceuticals in Nuclear Medical Sales by Type (2022-2027) & (K MT)
Table 57. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2022-2027)
Table 58. Europe Radiopharmaceuticals in Nuclear Medical Sales by Application (2016-2021) & (K MT)
Table 59. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
Table 60. Europe Radiopharmaceuticals in Nuclear Medical Sales by Application (2022-2027) & (K MT)
Table 61. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2022-2027)
Table 62. China Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2016-2021)
Table 63. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2016-2021)
Table 64. China Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2016-2021)
Table 66. China Radiopharmaceuticals in Nuclear Medical Sales by Type (2016-2021) & (K MT)
Table 67. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
Table 68. China Radiopharmaceuticals in Nuclear Medical Sales by Type (2022-2027) & (K MT)
Table 69. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2022-2027)
Table 70. China Radiopharmaceuticals in Nuclear Medical Sales by Application (2016-2021) & (K MT)
Table 71. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
Table 72. China Radiopharmaceuticals in Nuclear Medical Sales by Application (2022-2027) & (K MT)
Table 73. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2022-2027)
Table 74. Japan Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2016-2021)
Table 75. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2016-2021)
Table 76. Japan Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2016-2021)
Table 78. Japan Radiopharmaceuticals in Nuclear Medical Sales by Type (2016-2021) & (K MT)
Table 79. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
Table 80. Japan Radiopharmaceuticals in Nuclear Medical Sales by Type (2022-2027) & (K MT)
Table 81. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2022-2027)
Table 82. Japan Radiopharmaceuticals in Nuclear Medical Sales by Application (2016-2021) & (K MT)
Table 83. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
Table 84. Japan Radiopharmaceuticals in Nuclear Medical Sales by Application (2022-2027) & (K MT)
Table 85. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2022-2027)
Table 98. India Radiopharmaceuticals in Nuclear Medical Sales (K MT) by Company (2016-2021)
Table 99. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2016-2021)
Table 100. India Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2016-2021)
Table 102. India Radiopharmaceuticals in Nuclear Medical Sales by Type (2016-2021) & (K MT)
Table 103. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
Table 104. India Radiopharmaceuticals in Nuclear Medical Sales by Type (2022-2027) & (K MT)
Table 105. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2022-2027)
Table 106. India Radiopharmaceuticals in Nuclear Medical Sales by Application (2016-2021) & (K MT)
Table 107. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
Table 108. India Radiopharmaceuticals in Nuclear Medical Sales by Application (2022-2027) & (K MT)
Table 109. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2022-2027)
Table 110. Bracco Imaging Corporation Information
Table 111. Bracco Imaging Description and Business Overview
Table 112. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product
Table 114. Bracco Imaging Recent Development
Table 115. Cambridge Isotope Laboratories Corporation Information
Table 116. Cambridge Isotope Laboratories Description and Business Overview
Table 117. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product
Table 119. Cambridge Isotope Laboratories Recent Development
Table 120. Cardinal Health Corporation Information
Table 121. Cardinal Health Description and Business Overview
Table 122. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product
Table 124. Cardinal Health Recent Development
Table 125. Medtronic Corporation Information
Table 126. Medtronic Description and Business Overview
Table 127. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Medtronic Radiopharmaceuticals in Nuclear Medical Product
Table 129. Medtronic Recent Development
Table 130. Eczacibasi-Monrol Corporation Information
Table 131. Eczacibasi-Monrol Description and Business Overview
Table 132. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product
Table 134. Eczacibasi-Monrol Recent Development
Table 135. Fujifilm Holdings Corporation Corporation Information
Table 136. Fujifilm Holdings Corporation Description and Business Overview
Table 137. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product
Table 139. Fujifilm Holdings Corporation Recent Development
Table 140. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 141. GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
Table 142. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product
Table 144. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table 145. IBA Group Corporation Information
Table 146. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. IBA Group Description and Business Overview
Table 148. IBA Group Radiopharmaceuticals in Nuclear Medical Product
Table 149. IBA Group Recent Development
Table 150. Lantheus Medical Imaging Corporation Information
Table 151. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Lantheus Medical Imaging Description and Business Overview
Table 153. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product
Table 154. Lantheus Medical Imaging Recent Development
Table 155. Nordion Corporation Information
Table 156. Nordion Description and Business Overview
Table 157. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Nordion Radiopharmaceuticals in Nuclear Medical Product
Table 159. Nordion Recent Development
Table 160. Ntp Radioisotopes Corporation Information
Table 161. Ntp Radioisotopes Description and Business Overview
Table 162. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product
Table 164. Ntp Radioisotopes Recent Development
Table 165. Siemens Healthcare Corporation Information
Table 166. Siemens Healthcare Description and Business Overview
Table 167. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product
Table 169. Siemens Healthcare Recent Development
Table 170. Taiyo Nippon Sanso Corporation Corporation Information
Table 171. Taiyo Nippon Sanso Corporation Description and Business Overview
Table 172. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product
Table 174. Taiyo Nippon Sanso Corporation Recent Development
Table 175. Urenco Limited Corporation Information
Table 176. Urenco Limited Description and Business Overview
Table 177. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product
Table 179. Urenco Limited Recent Development
Table 180. Rotem Industries Corporation Information
Table 181. Rotem Industries Description and Business Overview
Table 182. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product
Table 184. Rotem Industries Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Radiopharmaceuticals in Nuclear Medical Distributors List
Table 188. Radiopharmaceuticals in Nuclear Medical Customers List
Table 189. Radiopharmaceuticals in Nuclear Medical Market Trends
Table 190. Radiopharmaceuticals in Nuclear Medical Market Drivers
Table 191. Radiopharmaceuticals in Nuclear Medical Market Challenges
Table 192. Radiopharmaceuticals in Nuclear Medical Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals in Nuclear Medical Product Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2021 & 2027
Figure 3. Diagnostic Radiopharmaceuticals Product Picture
Figure 4. Therapy Radiopharmaceuticals Product Picture
Figure 5. Enriched Stable Isotopes Product Picture
Figure 6. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2021 & 2027
Figure 7. Diagnostic Application Examples
Figure 8. Therapeutic Application Examples
Figure 9. Research Examples
Figure 10. Pharmaceutical Examples
Figure 11. Industrial Examples
Figure 12. Global Radiopharmaceuticals in Nuclear Medical Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Radiopharmaceuticals in Nuclear Medical Sales (K MT) Growth Rate (2016-2027)
Figure 15. Global Radiopharmaceuticals in Nuclear Medical Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 16. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Radiopharmaceuticals in Nuclear Medical Sales (K MT) Growth Rate (2016-2027)
Figure 20. Europe Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Radiopharmaceuticals in Nuclear Medical Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Radiopharmaceuticals in Nuclear Medical Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Radiopharmaceuticals in Nuclear Medical Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Radiopharmaceuticals in Nuclear Medical Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Radiopharmaceuticals in Nuclear Medical Players Market Share by Revenue in Radiopharmaceuticals in Nuclear Medical: 2016 & 2020
Figure 31. Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Type (2016-2021)
Figure 33. Global Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Application (2016-2021)
Figure 35. Global Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2020
Figure 37. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2020
Figure 38. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2020
Figure 39. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2020
Figure 40. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2020
Figure 41. China Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2020
Figure 42. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2020
Figure 43. Japan Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2020
Figure 44. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2020
Figure 45. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2020
Figure 46. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2020
Figure 47. India Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medical
Figure 50. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
Figure 51. Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed